• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR RX ACCULINK CAROTID STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR RX ACCULINK CAROTID STENT SYSTEM Back to Search Results
Catalog Number UNKNOWN RX ACCULINK
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Myocardial Infarction (1969); Tissue Damage (2104); Transient Ischemic Attack (2109); Stenosis (2263)
Event Date 01/01/2014
Event Type  Injury  
Manufacturer Narrative
Date of event: date is estimated.The udi is unknown as individual part and lot numbers were not provided.The device was not returned for analysis.The lot history record (lhr) for this product could not be reviewed because the product was not returned for evaluation and the lot number was not reported.In this case, there was no reported device malfunction associated with the rx acculink.The reported patient effects of stenosis, vessel damage, myocardial infarction (mi), stroke, and transient ischemic attack (tia) are listed in the rx acculink instructions for use as known potential adverse events associated with the use of a stent in carotid arteries.Based on the case information, a conclusive cause for the reported patient effects of stenosis, vessel damage, mi, stroke, and tia, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.The additional patient effect of death referenced is being filed under a separate medwatch report number.Reported attached: ¿vascular quality initiative, medical device report prepared for abbott vascular, rx acculink carotid stent system.".
 
Event Description
It was reported through a post-market clinical follow-up (pmcf) report that the acculink carotid artery stent may be related to stroke, mi, access site complication, post-procedural tia, recurrent carotid restenosis, re-treatment (percutaneous and surgical), and death.A device malfunction was not reported.Specific patient information is documented as unknown.Details are provided in the attached pmcf report, vascular quality initiative, medical device report prepared for abbott vascular, rx acculink carotid stent system.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RX ACCULINK CAROTID STENT SYSTEM
Type of Device
CAROTID STENT
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key11135544
MDR Text Key225807976
Report Number2024168-2021-00243
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040012
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Reporter Occupation Physician
Type of Report Initial
Report Date 01/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/07/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNKNOWN RX ACCULINK
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/18/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
Patient Age70 YR
-
-